Intracavitary VEGF, bFGF, IL-8, IL-12 levels in primary and recurrent malignant glioma
- 1 January 2003
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 62 (3) , 297-303
- https://doi.org/10.1023/a:1023367223575
Abstract
Intracavitary levels of VEGF, bFGF, IL-8 and IL-12 were evaluated by ELISA in 45 patients, 7 with recurrent anaplastic astrocytoma (rAA), 12 with glioblastoma (GBM) and 26 with recurrent glioblastoma...Keywords
This publication has 21 references indexed in Scilit:
- Prognostic Value of Vascular Endothelial Growth Factor and its Receptors Flt-1 and Flk-1 in Astrocytic TumoursActa Neurochirurgica, 2001
- Clinical Implications of Circulating Angiogenic Factors in Cancer PatientsJournal of Clinical Oncology, 2001
- Efficacy of intratumoral delivery of mitoxantrone in recurrent malignant glial tumours.Journal of Neuro-Oncology, 2001
- Relationship between plasma levels of vascular endothelial growth factor and serum levels of interleukin-12 in patients with colorectal cancer.2000
- Vascular endothelial growth factor production in polymyalgia rheumaticaArthritis & Rheumatism, 2000
- Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastomaOncogene, 1999
- Elevated Plasma Basic Fibroblast Growth Factor in Brain Tumor PatientsNeurologia medico-chirurgica, 1996
- Inhibition of Angiogenesis In Vivo by Interleukin 12JNCI Journal of the National Cancer Institute, 1995
- Detection and Quantification of Vascular Endothelial Growth Factor/Vascular Permeability Factor in Brain Tumor Tissue and Cyst FluidNeurosurgery, 1994
- Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumoursThe Lancet, 1994